Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

Lanthanide-to-quantum dot Förster resonance energy transfer (FRET): Application for immunoassay.

Goryacheva OA, Beloglazova NV, Vostrikova AM, Pozharov MV, Sobolev AM, Goryacheva IY.

Talanta. 2017 Mar 1;164:377-385. doi: 10.1016/j.talanta.2016.11.054. Epub 2016 Nov 30. Review.

PMID:
28107944
2.

Generation of stretched pulses and dissipative solitons at 2  μm from an all-fiber mode-locked laser using carbon nanotube saturable absorbers.

Wang Y, Alam SU, Obraztsova ED, Pozharov AS, Set SY, Yamashita S.

Opt Lett. 2016 Aug 15;41(16):3864-7. doi: 10.1364/OL.41.003864.

PMID:
27519109
3.

Generation regimes of bidirectional hybridly mode-locked ultrashort pulse erbium-doped all-fiber ring laser with a distributed polarizer.

Krylov AA, Chernykh DS, Arutyunyan NR, Grebenyukov VV, Pozharov AS, Obraztsova ED.

Appl Opt. 2016 May 20;55(15):4201-9. doi: 10.1364/AO.55.004201.

PMID:
27411151
4.

Hybrid mode-locked erbium-doped all-fiber soliton laser with a distributed polarizer.

Chernykh DS, Krylov AA, Levchenko AE, Grebenyukov VV, Arutunyan NR, Pozharov AS, Obraztsova ED, Dianov EM.

Appl Opt. 2014 Oct 10;53(29):6654-62. doi: 10.1364/AO.53.006654.

PMID:
25322366
5.

[Critical conditions as a logical and appropriate series of events in iron methabolism disorders (the summary of experimental studies)].

Orlov IuP, Lukach VN, Dolgikh VT, Soboleva EL, Ivanova AV, Liubavina AÉ, Ivanova AM, Boltruchenko AS, Boronenko VV, Kozhevnikova EF, Pozharov SV.

Biomed Khim. 2013 Nov-Dec;59(6):700-9. Russian.

PMID:
24511682
6.

Nanotechnology approaches for personalized treatment of multidrug resistant cancers.

Minko T, Rodriguez-Rodriguez L, Pozharov V.

Adv Drug Deliv Rev. 2013 Nov;65(13-14):1880-95. doi: 10.1016/j.addr.2013.09.017. Epub 2013 Oct 10. Review.

7.

Thulium-doped mode-locked all-fiber laser based on NALM and carbon nanotube saturable absorber.

Chernysheva MA, Krylov AA, Kryukov PG, Arutyunyan NR, Pozharov AS, Obraztsova ED, Dianov EM.

Opt Express. 2012 Dec 10;20(26):B124-30. doi: 10.1364/OE.20.00B124.

PMID:
23262842
8.

Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2.

Ivanova V, Garbuzenko OB, Reuhl KR, Reimer DC, Pozharov VP, Minko T.

Eur J Pharm Biopharm. 2013 Jun;84(2):335-44. doi: 10.1016/j.ejpb.2012.11.023. Epub 2012 Dec 8.

9.

Transform-limited pulse generation in normal cavity dispersion erbium doped single-walled carbon nanotubes mode-locked fiber ring laser.

Chernysheva MA, Krylov AA, Ogleznev AA, Arutyunyan NR, Pozharov AS, Obraztsova ED, Dianov EM.

Opt Express. 2012 Oct 8;20(21):23994-4001. doi: 10.1364/OE.20.023994.

PMID:
23188366
10.

Passive synchronization of all-fiber lasers through a common saturable absorber.

Zhang M, Kelleher EJ, Pozharov AS, Obraztsova ED, Popov SV, Taylor JR.

Opt Lett. 2011 Oct 15;36(20):3984-6. doi: 10.1364/OL.36.003984.

PMID:
22002360
11.

Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance.

Garbuzenko OB, Saad M, Pozharov VP, Reuhl KR, Mainelis G, Minko T.

Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10737-42. doi: 10.1073/pnas.1004604107. Epub 2010 May 24.

12.

Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery.

Taratula O, Garbuzenko OB, Kirkpatrick P, Pandya I, Savla R, Pozharov VP, He H, Minko T.

J Control Release. 2009 Dec 16;140(3):284-93. doi: 10.1016/j.jconrel.2009.06.019. Epub 2009 Jun 28.

13.

Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug.

Garbuzenko OB, Saad M, Betigeri S, Zhang M, Vetcher AA, Soldatenkov VA, Reimer DC, Pozharov VP, Minko T.

Pharm Res. 2009 Feb;26(2):382-94. doi: 10.1007/s11095-008-9755-4. Epub 2008 Oct 29.

PMID:
18958402
14.

Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging?

Saad M, Garbuzenko OB, Ber E, Chandna P, Khandare JJ, Pozharov VP, Minko T.

J Control Release. 2008 Sep 10;130(2):107-14. doi: 10.1016/j.jconrel.2008.05.024. Epub 2008 Jun 25.

15.

Nonviral nanoscale-based delivery of antisense oligonucleotides targeted to hypoxia-inducible factor 1 alpha enhances the efficacy of chemotherapy in drug-resistant tumor.

Wang Y, Saad M, Pakunlu RI, Khandare JJ, Garbuzenko OB, Vetcher AA, Soldatenkov VA, Pozharov VP, Minko T.

Clin Cancer Res. 2008 Jun 1;14(11):3607-16. doi: 10.1158/1078-0432.CCR-07-2020.

16.

Chronic hypoxia in Andeans; are there lessons for neurology at sea level?

Appenzeller O, Minko T, Qualls C, Pozharov V, Gamboa J, Gamboa A, Pakunlu RI.

J Neurol Sci. 2006 Aug 15;247(1):93-9. Epub 2006 Jun 2.

PMID:
16733057
17.

Gene expression, autonomic function and chronic hypoxia:lessons from the Andes.

Appenzeller O, Minko T, Qualls C, Pozharov V, Gamboa J, Gamboa A, Wang Y.

Clin Auton Res. 2006 Jun;16(3):217-22. Epub 2006 Apr 1.

PMID:
16583294
18.

Novel polymeric prodrug with multivalent components for cancer therapy.

Khandare JJ, Chandna P, Wang Y, Pozharov VP, Minko T.

J Pharmacol Exp Ther. 2006 Jun;317(3):929-37. Epub 2006 Feb 9.

19.

Migraine in the Andes and headache at sea level.

Appenzeller O, Minko T, Qualls C, Pozharov V, Gamboa J, Gamboa A, Wang Y.

Cephalalgia. 2005 Dec;25(12):1117-21.

PMID:
16305600
20.

Remediation of cellular hypoxic damage by pharmacological agents.

Minko T, Wang Y, Pozharov V.

Curr Pharm Des. 2005;11(24):3185-99. Review.

PMID:
16178753

Supplemental Content

Loading ...
Support Center